首页|血清LTBP-2、COMP水平与ST段抬高型心肌梗死患者病情、预后的关系

血清LTBP-2、COMP水平与ST段抬高型心肌梗死患者病情、预后的关系

Relationship between serum LTBP-2,COMP levels and the condition,prognosis of patients with ST-segment elevation myo-cardial infarction

扫码查看
目的 分析ST段抬高型心肌梗死(STEMI)患者血清潜在转化生长因子结合蛋白2(LTBP-2)和软骨寡聚基质蛋白(COMP)的表达水平,探讨其与患者的病情及预后的关系.方法 以2019年1月至2020年12月郑州大学第五附属医院收治的135例STEMI患者为STEMI组,另外选取135名健康体检人员为对照组,STEMI患者根据出院1年随访中是否出现主要不良心脏事件(MACE)分为MACE组和非MACE组;ELISA法检测血清中LTBP-2和COMP的表达水平;采用Pearson法分析STEMI组患者LTBP-2与COMP表达的相关性;采用多因素logistic回归分析影响STEMI患者术后出现MACE的危险因素.结果 与对照组相比,STEMI组患者的LTBP-2、COMP表达水平以及饮酒史、吸烟史的人数升高(P<0.05);Gensini积分≤38分的STEMI患者血清LTBP-2、COMP水平明显低于Gensini积分>38分的患者(P<0.05);Pearson法分析显示,STEMI患者血清中LTBP-2和COMP表达呈正相关(r=0.660,P<0.05);STEMI患者术后出现MACE的例数为30/135(22.22%),MACE组患者中发病时间>6 h,Gensini积分>38分、Killip分级Ⅲ~Ⅳ级比例、支架植入个数、血清LTBP-2与COMP表达水平明显高于非MACE组(P<0.05);多因素logistic回归分析表明,发病时间>6 h、Gensini积分>38分、Killip分级Ⅲ~Ⅳ级、支架植入个数≥3、LTBP-2≥39.36 ng/mL 和 COMP≥35.73 ng/mL 是影响 STEMI 患者术后出现 MACE 的危险因素(P<0.05).结论 STEMI患者血清中LTBP-2、COMP的表达水平升高,二者与STEMI患者的病情严重程度及预后密切相关.
Objective To analyze the serum expression levels of latent-transforming growth factor beta-binding pro-tein-2(LTBP-2)and cartilage oligomeric matrix protein(COMP)in patients with ST-segment elevation myocardial in-farction(STEMI),and to explore their relationship with the condition and prognosis.Methods From January 2019 to December 2020,135 STEMI patients admitted to our hospital were regarded as the STEMI group,another 135 healthy people were regarded as the control group.STEMI patients were grouped into MACE group and non-MACE group ac-cording to whether major adverse cardiac events(MACE)occurred during 1-year follow-up after discharge;the expres-sion levels of LTBP-2 and COMP in serum were detected by ELISA;Pearson's method was applied to analyze the cor-relation between the expression of LTBP-2 and COMP in STEMI group;multivariate logistic regression analysis was applied to analyze the risk factors of postoperative MACE in STEMI patients.Results Compared with the control group,the STEMI group had an increase in LTBP-2 and COMP expression levels,as well as a history of alcohol con-sumption and smoking(P<0.05);levels of serum LTBP-2 and COMP in STEMI patients with Gensini score ≤38 points were obviously lower than those in STEMI patients with Gensini score>38 points(P<0.05);Pearson's meth-od analysis showed that the expression of LTBP-2 and COMP in the serum of STEMI patients was positively correlated(r=0.660,P<0.05);the number of STEMI patients with postoperative MACE was 30/135(22.22%),the onset time>6 h,the Gensini score>38 points,the proportion of Killip grades Ⅲ to Ⅳ,the number of implanted stents,and the expression levels of serum LTBP-2 and COMP in the MACE group were obviously higher than those in the non-MACE group(P<0.05);multivariate logistic regression analysis showed that onset time>6 h,Gensini score>38 points,Kil-lip grade Ⅲ~Ⅳ,number of stents ≥3,LTBP-2 ≥39.36 ng/mL and COMP ≥35.73 ng/mL were risk factors for postoperative MACE in STEMI patients(P<0.05).Conclusion The expression levels of LTBP-2 and COMP in serum of STEMI patients are increased,and they are closely related to the severity and prognosis of STEMI patients.

LTBP-2COMPST-segment elevation myocardial infarctionmajor adverse cardiac events

付艳华、陈炅、郭华

展开 >

郑州大学第五附属医院老年医学科,河南郑州 450052

郑州大学第五附属医院急诊科,河南郑州 450052

LTBP-2 COMP ST段抬高型心肌梗死 主要不良心脏事件

2024

中国实验诊断学
吉林大学中日联谊医院 上海交通大学医学院附属瑞金医院

中国实验诊断学

CSTPCD
影响因子:1.273
ISSN:1007-4287
年,卷(期):2024.(9)